ACSM Blog
Menu

In This Section:

  • Heart Health & Brain Health Go Hand-in-Hand

    by Caitlin Kinser | Feb 22, 2019

    In February, we often see many people wearing the color Red. Wearing Red may be a tribute to St. Valentine, but the color Red should also serve as a reminder to take care of our hearts, as February is Heart Disease Month! According to the Center of Disease Control and Prevention, heart disease accounts for one of every four deaths in the United States. Many of the causes of heart disease are well-known, including hypertension, hyperlipidemia, diabetes and obesity. Fortunately, there are also well-known lifestyle and behavior changes that can drastically reduce the risk of heart disease and include: smoking cessation, eating a healthy diet and exercising.

    Despite the multitude of data showing that lifestyle behaviors can reduce the risk of heart disease and improve cardiovascular health, the Framingham Offspring Study recently reported that the percentage of people with ideal cardiovascular health (using the American Heart Association’s definition of Ideal Cardiovascular Health) has declined over the past 20 years.

    Even in the absence of heart disease, the increasing percentage of Americans with less than ideal cardiovascular health translates to greater risk of heart disease and increased all-cause mortality. Because the heart and cardiovascular system are vital factors in overall health, other organ systems will be affected by less-than-ideal cardiovascular health. Importantly, adults having an ideal cardiovascular health score during the middle-aged years had a lower risk of cognitive decline and dementia. In addition, large-scale epidemiological studies have continued to show a strong correlation between cardiovascular health and brain health. 

    What is the link between cardiovascular health and brain health?

    It is possible that heart disease and Alzheimer’s disease or dementia have common risk factors and that is why there are correlations between these conditions. However, the brain requires a large amount of blood flow, which needs to be precisely controlled to maintain optimal neuronal function. If a patient has a problem with the function of the heart or blood vessels, this could prevent adequate blood flow supply to the brain and eventually affect brain function and cognition. We know that patients with congestive heart failure have higher incidence of dementia. In heart failure patients, a reduced capacity of the left ventricle to pump blood (i.e. ejection fraction) is associated with poor cognitive test scores

    The function of the large vessels supplying blood flow to the brain are also important to overall brain health. A paper published almost 70 years ago first reported that patients with carotid occlusion (due to atherosclerosis) eventually progressed to dementia. This early case study was the first to suggest that mild hypoperfusion of the brain, due to large vessel stenosis, could lead to dementia. 

    Dysfunction in the heart (or pump) or the large blood vessels (or conduits) is associated with reduced cognitive function, but the small blood vessels in the brain that control the blood supply to neurons may also contribute to the link between cardiovascular health and brain health. This hypothesis was first proposed decades ago, based on evidence of disrupted microvessel structure in the brains of Alzheimer’s disease patients. Disruption in the microvessels can lead to hypoperfusion, disrupt the blood-brain-barrier or reduce the ability of the brain to utilize glucose. Collectively, an interruption at any segment of the blood delivery system (heart, large and small blood vessels) could impair the ability of the brain to function optimally.

    physical activity recommendationsNow, for the good news: Because of the link between heart health and brain health, we know that lifestyle behaviors (like exercise!) can reduce the risk of developing heart disease AND developing cognitive decline. Older adults who are more physically active have better brain health compared with sedentary counterparts, suggesting a protective effect of exercise. And although more research is necessary to determine how exercise may promote healthy brain aging and what might be the optimal training program, using what we know about what works for heart health and following ACSM’s guidelines for physical activity is a great place to start.

    Perhaps wearing Red in February should be a reminder to take care of our heart so that our heart can take care of our brain. 

     

    Jill Barnes, Ph.D., FACSM, is an Assistant Professor at the University of Wisconsin-Madison in the Department of Kinesiology and has an affiliate faculty appointment in the Division of Geriatrics and Gerontology in the School of Medicine and Public Health. 

  • Featured Event | Infusing Science in ACSM’s Health & Fitness Summit 2019

    by David Barr | Feb 13, 2019


    Why Should YOU Attend ACSM's International Health & Fitness Summit?


    In addition to CECs and Career Development opportunities, Renee Rogers, Ph.D., describes why infusing science throughout ACSM’s International Health and Fitness Summit benefits ACSM and attendees. 

    Learn more and register for the ACSM International Health & Fitness Summit at ACSMSummit.org!

    #ACSM #ACSMSummit
  • Heart Failure and Exercise: Uncovering Questions and Slowly Progressing Towards Truths

    by Caitlin Kinser | Feb 13, 2019

    Chronic heart failure (HF) is a global epidemic. For the greater than 26 million world-wide patients with HF, this burden does not just cause an impairment in how blood is pumped out of the heart, HF impacts how all organ systems function and interact with one another. This means that HF constitutes a multi-organ syndrome as opposed to a disease of a single organ system, making it difficult to identify a “cure.” Unfortunately for patients, this means the impact of HF is felt daily and universally experienced as exercise intolerance and inability to comfortably perform activities of daily living. Fatigue and shortness of breath quickly overcome patients soon after engaging in even the most basic exercise such as walking to get the mail or climbing household stairs.

    Since the seminal work of Weber and Janicki demonstrating that exercise intolerance does not simply impact the quality of life of HF patients, but is also strongly predictive of clinical severity, over 30 years have flown-by and we now know the “cure” for exercise intolerance is indeed the act of exercise itself. Despite this golden era of knowledge, there is a lot to be said about the pure translation of this rich information from “bench to bedside”.

    An encouraging and globally impactful effort towards the ACSM Exercise is Medicine approach for the management of HF was recognized at center-stage following the 2009 publication of HF-ACTION. A large number of patients with HF and reduced ejection fraction (HFrEF; left ventricular ejection fraction of 35% or less) were shown to safely and clearly benefit from extended and structured aerobic and strength exercise training (ET) therapy (36 sessions; 3x/week; over 12 weeks). With the findings from HF-ACTION underpinning the support needed for the eventual 2014 policy recommending that Centers for Medicare & Medicaid Services (CMS) provide coverage for cardiac rehabilitation (CR) therapy for patients with HFrEF, it was believed that a “magic pill” for curing exercise intolerance and related signs and symptoms had been found. If only the “cure” was as simple as literally taking a pill.

    Despite the exponential growth of studies, both domestic and international, since HF-ACTION supporting the medicinal role that ET therapy plays in managing signs and symptoms of HF, alarming underutilization of CR and ET continues to be reported (see here, here and here). Some important facts highlighted in recent reports focusing primarily on patients with HFrEF include:

    • Less than 13% of CMS eligible patients are likely to receive referral for CR at discharge.
    • Participation in at least one session of CR may be less than 3% out of all who are CMS eligible.
    • Stable outpatients referred to CR (97%) as opposed to hospitalized inpatients (17%) referred to CR upon discharge are more likely to enroll.

    What patients may not know is that CR is a Class I recommended therapy for HFrEF. This means CR is at the same status level as traditionally prescribed pharmacotherapies. Nevertheless, the data speaks for itself in illustrating the importance of the CR service-line has not been emphasized across the patient-to-clinician spectra to the point where it is appropriately being utilized.

    Although the statistics are disappointing, the temptation for assigning responsibility for shortcomings must be resisted. Instead, it is important to look forward to the future and realize that all of us can still make significant changes to the running narrative of what CR means for HF patients. The well-intentioned hope of CMS coverage for CR should not be lost. There are ambitious campaigns focusing on improving education and awareness for both patients and clinicians highlighting the importance of CR, secondary prevention and life-long participation in exercise and physical activity.

    Finally, conventional wisdom should lead all of us to the conclusion that ET therapy and HFrEF are not mutually exclusive events. Patients not classified as HFrEF, such as those diagnosed with HF and preserved ejection fraction (HFpEF; left ventricular ejection fraction of 50% or greater) or mid-range ejection fraction (HFmrEF; left ventricular ejection fraction of greater than 35% and less than 50%) are also logically to benefit from CR and ET therapy. There is no time sooner than now to force the narrative that all HF classes and etiologies stand to benefit from medically guided and individualized ET therapy.

    Erik H. Van Iterson, Ph.D., is a member of the clinical staff and is the Director of Cardiac Rehabilitation in the Section of Preventive Cardiology & Rehabilitation in the Heart and Vascular Institute at the Cleveland Clinic, Cleveland OH.

  • Industry Presented Blog | The Female Athlete Triad & Sports Nutrition Strategies for Recovery Webinar Q&A

    by David Barr | Feb 12, 2019

    Female Athlete Triad Webinar
    Viewpoints presented in this blog reflect opinions of the author and do not necessarily reflect positions or policies of ACSM.


    Gatorade Sports Science Institute (GSSI) and Dr. Mary Jane De Souza recently hosted an industry-presented webinar entitled: The Female Athlete Triad & Sports Nutrition Strategies for Recovery. Watch a free recorded version of the webinar here.

    Key Points: 

    1.
    Recovery of the Triad is dependent on nutritional therapy to reverse energy deficiency and low EA.

    2. Recovery of bone is dependent on increased body weight, fat mass and menses.

    3. Must consider energy status and estrogen for recovery and to make recommendations for return to health. If estrogen therapy is considered, transdermal is the best for women who fail one year of nutritional therapy and with worsening bone health.
     

    Several questions were asked by attendees during the webinar and the answers are below.

    GSSI logo
    Q: What is a normal time frame from chronic low EA to menstrual dysfunction? (when do the first symptoms appear?)

    Depending on your current menstrual status, where you are in your cycle, and the magnitude of energy deficiency, it may take weeks to months for menstrual disturbances to be observed. 

    Q: Does use of a birth control pill have an impact on energy availability?

    Oral contraceptives may be associated with changes in appetite or eating behaviors, but aside from that they do not directly alter energy availability.

    Q: Is there a clear relation between menstrual dysfunction and reproductive ability? and if so, will it always be reversible (when menstrual function is back to normal will an athlete have a normal reproduction capacity)?

    Anovulation, oligomenorrhea and amenorrhea can impact reproductive ability. We expect reproductive ability to resume once the menstrual irregularity is resolved and cycles become ovulatory again; however, there have not been any studies yet that have looked at fertility itself with respect to the Triad.

    Q: kcal/kg/FFM/day - How can this be used in the field where body comp is not known?  vs kcal/kg/bw?

    Correcting for body mass rather than fat free mass would likely result in an underestimation of EA.  There are several commercially available tools, such as Bio-electric Impedance Analysis (BIA) devices, that are available to estimate fat free mass that would be recommended in field assessments of EA.

    Q: How long should a menstrual cycle be absent before you are considered to have amenorrhea?

    Current Endocrine Society Clinical Practice Guidelines define functional hypothalamic amenorrhea as an absence of menses for 3 months or more.

    Q: I'm wondering how to identify menstruating and amenorrhea? Compare with themselves, or 28 days?

    Eumenorrheic menstrual cycles occur at regular intervals and last approximately 26-34 days.  Oligomenorrhea is characterized by long and irregular menstrual cycles, often longer than 36 days.  Amenorrhea is the absence of menses for 3 months or longer.

    Q: At the beginning of the presentation, you mentioned that this can also affect men. In addition to bone health, does this also affect hormones in males?

    There is some evidence that metabolic and reproductive hormones may be suppressed in men who have low energy availability or chronic energy deficiency.

    Q: Can females who menstruate regularly on the pill still have menstrual dysfunction (if they were not using the pill to regulate hormones) and is this just as dangerous for reproductive function?

    Use of oral contraceptives suppresses ovulation and menstrual function, as they are intended to prevent pregnancy and, since you have monthly bleeding, make it seem like you are having regular menstrual cycles. Bleeding while on the pill is not menstrual bleeding it is breakthrough bleeding stimulated by the pills.  The pill is not “dangerous” for reproductive function.  In a small number of women, when you stop the pill you may experience post-pill amenorrhea.  

    Q: Did you have a specific recommendation for the increased calorie group? I.e. a certain food or specific source of energy?

    For the REFUEL study, the intervention was only focused on increasing the total number of calories by 20-30% of baseline energy expenditure needs. An interesting topic for future research would be to determine if specific macronutrients are needed or if increased calories of any macronutrient composition are adequate to have positive benefits.

    Q: Having your athlete be on a birth control pill for regular menses will this prevent bone loss?

    OCs are processed by the liver, which leads to decreased hepatic IGF-1 production, contributing to potential negative impacts on bone health.  OC’s are not the best strategy to prevent bone loss.  Contraception in the form of a patch or vaginal ring to avoid first-pass effects on hepatic IGF-1 production likely will yield better outcomes on bone.

    Q: Specifically, around the question of 45 kcal/kg/FFM/day? How do we determine this?

    EA is calculated as energy intake (kcal) – exercise energy expenditure (kcal) / fat free mass (kg).

    Simple assessments of energy availability can utilize diet logs for energy intake, exercise logs or the Compendium of Physical Activity for energy expenditure, and bioelectrical impedance or skinfolds for fat free mass.

    Q: In the study, when the calories were increased in the oligo/amenorrhoeic, was the quality of the calories taken into consideration, e.g., calories from fat vs carbohydrate, etc.?

    For the REFUEL study, macronutrient composition was not considered.  This intervention was only focused on increasing the total number of calories.

    Q. Does phytoestrogen supplementation can alleviate negative impact of subclinical/clinical MD on bone health?

    There is some data in postmenopausal women that phytoestrogens may help with bone problems to a small extent.

    Q: Do you look at hemoglobin to look at energy levels? Regular menses can affect.

    To date, not much research is present to determine the impact of iron status on Triad-related conditions. We do have one study that shows the ovulatory eumenorrheic women do have a higher prevalence of iron depletion compared to amenorrhoeic women, the two groups do not differ in serum ferritin levels, hemoglobin, hematocrit, or total body iron. More research is necessary to investigate whether iron impacts bone health in this population.

    Q: Intermittent fasting seems to be the new hot topic. What is your take on athletes taking part in intermittent fasting?

    Some studies have begun to look at within-day fluctuations in energy availability.  It is possible that diet patterning which produces severe energy deficits throughout the day, even if 24-hour diet goals are met, may result in negative health outcomes.

    Q: Does the recommendation also apply to those who have hypothyroidism? Hyperthyroidism?

    We excluded women with thyroid conditions from our study.

    Q: Can any of this be correlated to menopause?  Have there been any studies following this information?

    It would be interesting to see how the bone health of previously amenorrhoeic athletes is when they get to be menopausal- but no, we do not have any data to date on this issue.

    Q: Even in college athletes you would consider waiting a year before starting hormone replacement knowing they may lose a year of participation?

    Because the root of Triad is inadequate energy, the recommended first course of action is to start nutritional therapy for one year to increase energy levels. This should start to recover menstrual status after a few months. If the athlete fails to complete nutritional therapy for a year (i.e. does not consume enough calories to resume normal menses), the physician working with the athlete could then consider hormone therapy, preferably in the form of patch or vaginal ring to avoid first-pass effects on hepatic IGF-1 production.

    Q: Is it possible to have amenorrhea or oligomenorrhea without possibility of bone damage?

    Not likely. The extent of bone loss with amenorrhea/oligomenorrhea would be dependent on the length of time without regular menses. Estrogen production is extremely important for inhibiting the osteoclasts responsible for bone resorption, and therefore the longer you are without normal estrogen levels (i.e. when you are not menstruating regularly), the more active these cells are at breaking down bone. If energy status is improved relatively early on, this could help prevent the progression of bone loss.

    Q: What about postmenopausal athletes and bone recovery with nutrition support - is it possible without pharmacy?

    Because estrogen levels are drastically reduced with menopause, bone health is at risk during this time.  Along with proper nutrition and adequate food consumption, the Food and Nutrition Board (FNB) recommends that post-menopausal women supplement with calcium and vitamin D to the recommended daily value of 1200 mg of Calcium and 600-800 IU Vitamin D. But be advised that pharmacological therapy may be necessary for postmenopausal bone loss. 

    Q: What impact does age have?  Comparing a 20-year-old to a 40-year-old, with other factors being similar?

    Women who are of greater gynecological age (farther from having their first period) seem to be more robust against menstrual disturbances.  Younger women may also still be accruing bone density so it is especially important for them to maximize their peak bone mineral density, whereas older women may only need to maintain their bone mass.

    Q: What type of supplement/vitamins do you recommend for low density athletes?

    Calcium and vitamin D are important contributors to bone health. The FNB at the Institute of Medicine recommends adults to take between 1000-1200mg calcium and 600-800 IU vitamin D daily.

    Q: What are your recommendations for vitamin D supplementation?

    The recommended daily allowance established by the FNB at the Institute of Medicine of the National Academies recommends 600 IU daily for people ages 13-50 and 600-800 IU daily for people ages 51 and older. 

    Q: What about psychological therapy?

    A mental health practitioner should be included in the multi-disciplinary team for Triad treatment, especially when disordered eating behaviors or clinical eating disorders are present.

    Q: Can you explain the physiology as to why OA athletes would have a 27% increase in fractures versus an Anorexic athlete?

    The 27% increase was specific to stress fractures.

    Q: Is it possible that despite a decrease in BMD, bone structure can be maintained so that the bone remains functional and strong with low risk of stress fractures?

    One possibility of why jockeys don’t have stress fractures is due to it being a non-loading activity, many of the fractures encountered in this population are of the traumatic type from falls.  We don’t yet know whether bone geometry can be recovered or if it can be maintained despite decreases in BMD.

    Q: My question is regarding my personal experience with the F.A.T. I have been recovered from an eating disorder and amenorrhea for one year, but my bone health has not changed. I am still in the osteopenia category. I do have a history of stress fractures in my pelvis. My question is, at the age of 22, if there hope that I can reverse some of the bone loss? Should I consider pharmacological approach with my doctor?

    Remember that bone health takes the longest to recover when you are along the spectrum of the Triad, and may also be impacted by the length of time for which you were dealing with the eating disorder and amenorrhea. While there is no current research to suggest that bone loss can be fully reversed, increasing your energy intake and achieving menstrual regularity is the first big step towards improvement. If you aren’t already taking calcium and vitamin D, please consult with your physician to include this in your recovery plan before seeking other pharmacological interventions.

    Q: Does bone loss occur in perimenopausal and postmenopausal women on low energy diets?

    Because estrogen levels are drastically reduced during the menopausal transition, this leads to decrements of 1-2% of bone mineral density per year. Along with proper nutrition and adequate food consumption, the Food and Nutrition Board (FNB) recommends that post-menopausal women supplement with calcium and vitamin D to the recommended daily value of 1200 mg of calcium and 600-800 IU Vitamin D. 

    Q: Does age of athletes (adolescent vs women in their 30's) have any impact on treatment and resolution of symptoms?

    Yes, you must check skeletal maturity issues in young athletes.

    Q: Did the participants in your study track intake using an online tool e.g. MyFitnessPal or SparkPeople or keep a hand journal?

    We utilize hand journals, but online tools can also be useful especially to individuals tracking their own intake.

    Q: The menstrual cycle is a great indicator of the FAT in women - is there an equivalent for men and the MAT?

    The Male Athlete Triad is likely more difficult to diagnose for that reason.  One symptom that may be readily observed is a decrease in libido.

    Q: Women who take part in sports normally should have periods monthly, thus, my question on periods. Let us suppose we are talking about professional long-distance runners. We are aware of the deficits in performance that periods may have on women. Hence, what diets are the most appropriate for women to maintain their training regime and ensure they perform on race day?

    There is NO data available to show that menstrual bleeding is detrimental to performance. We NEVER recommend trying to induce amenorrhea.

    Q: Is it possible to recover BMD in mater athletes after menopause?

    Women should work towards maintaining their bone mineral density as they go through menopause. Along with proper nutrition and adequate food consumption, the Food and Nutrition Board (FNB) recommends that post-menopausal women supplement with calcium and vitamin D to the recommended daily value of 1200 mg of calcium and 600-800 IU Vitamin D.  If losing bone, they should discuss strategies with their Dr.

    Q: Transdermal estrogen is associated with increased risk of DVT, isn't it?

    There is an increased risk dependent on the type of progestin the preparation.

    Q: When you mentioned a 200 approx. increase in calories, for how long do you recommend maintaining this amount before trying to increase a little extra if no effects are seeing?

     If you start small say 200kcals, you can increase kcals after two to four weeks to get a better chance of recovery.

    Q: Why in the REFUEL study the increase in energy intake was increased by 20-30% of EEE and not aimed at 45 kcal/FFM/day?

    Because that volume of calories would have likely been too high to ask the women to eat and we would likely have been unsuccessful.

    Q: Could you address the average kcal per kg to resume menses from your study? You mentioned the highest amount was ~445 kcals, but how many kcals per kg was this?

    We are in the process of analyzing the data- watch for our publications.

    Q: When calculating EA, what is your recommendation on how to estimate energy intake and exercise energy expenditure?

    Energy intake can be assessed by 3-day diet logs or online diet recording tools.  Exercise energy expenditure can be assessed using exercise logs matched with heart rate monitors or using the Compendium of Physical Activity.

    Q: Which type of sports are most likely to result in effecting menstrual cycle disturbances?

    Menstrual dysfunction is more commonly observed in leanness sports which emphasize a low body weight for competitive or aesthetic purposes, as in endurance, weight-class, or anti-gravity activities.

    Q: What do you think about doing screening DEXA scan for BMD and body composition on all incoming collegiate female athletes?

    A screening DXA would be a valuable piece of information for these athletes to have, particularly because most do not realize that their eating behaviors/ inadequate consumption have detrimental consequences on bone health. This would also help identify those in need of dietary intervention early in their collegiate career. This would also provide useful information to the athletes regarding their health.

    Author: Mary Jane De Souza

    Dr. Mary Jane De Souza, Professor of Kinesiology and Physiology at Penn State University.  Dr. De Souza is a preeminent researcher in the area of the physiological basis of exercise and how it modulates reproductive function and bone health through alterations in energy balance.  Dr. De Souza’s specific research “niche” has been defined by a series of studies demonstrating significant associations of menstrual disturbances, metabolic adaptation, and bone health.  Among her many recognitions, Dr. De Souza is a recipient of the prestigious Citation Award from the American College of Sport Medicine for her lifetime achievement in research, and the Honor Award from the New England Chapter of the American College of Sports Medicine.
  • CEC Feature: Heart Rate Monitoring Assessment Course - POLAR and ACSM

    by David Barr | Feb 08, 2019

    POLAR ACSM Course



    Earn 6 Continuing Education Credits


    Course Overview: Learn how to build an effective heart rate-based training program, along with foundational knowledge of the physiology of heart rate. This course will primarily focus on utilizing five heart rate training zones through the exercise disciplines of cycling and running. In addition, utilizing online platforms such as Polar Flow and TrainingPeaks to manage heart rate training will be addressed.

    After completing this course, you’ll understand how to utilize all training heart rate zones to build effective endurance programs and address specific training obstacles that may present themselves throughout a program.

    Learning Objectives

    •             Learn the exercise physiology of heart rate assessment and how to perform maximal and sub-maximal VO2 field testing.

    •             Learn how to effectively build a heart rate-based training program utilizing the five heart rate training zones.

    •             Learn the importance of respiratory muscle training within a heart rate-based training programs.

    Earn 6 CECs in our NEW Online Learning Platform

...121122123124125126127128129130...